Brevan Howard Capital Management’s Select Medical SEM Stock Holding History

Brevan Howard Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-82,027	Closed	-$1.34M	–	2525
2026 Q1	$1.34M	Buy	82,027 +41,732	+104%	+$653K	0.01%	753
2025 Q4	$598K	Sell	40,295 -2,776	-6%	-$39.2K	0.01%	1012
2025 Q3	$553K	Buy	+43,071	New	+$574K	﹤0.01%	1238
2025 Q1	–	Sell	-33,986	Closed	-$641K	–	1429
2024 Q4	$641K	Buy	33,986 +2,512	+8%	+$48.4K	﹤0.01%	546
2024 Q3	$591K	Buy	+31,474	New	+$603K	﹤0.01%	636

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Brevan Howard Capital Management's SEM Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Select Medical (SEM) in Q2 2026, closing a stake of 82,027 shares — an estimated $1.34M sold.

Brevan Howard Capital Management first reported a position in SEM in Q3 2024 and held it in 5 quarters. The position peaked at $1.34M in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Brevan Howard Capital Management reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 82,027 Select Medical shares in Q2 2026, an estimated $1.34M.
Brevan Howard Capital Management first reported a position in Select Medical in Q3 2024 and held it in 5 quarters.
Brevan Howard Capital Management's Select Medical position peaked at $1.34M in Q1 2026.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.